Scientists Seek to Develop New and Better Ways to Look at Existing Data At CHI’s “World Pharmaceutical Congress” held recently in Philadelphia, there was no shortage of good ideas for ways to optimize ...

This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...

The main challenge in the process of taking a hit to a lead in drug discovery is figuring “what questions to ask and what information will best help focus lead optimization,” said Simon Hirst, Ph.D., ...

CHENGDU, China--(BUSINESS WIRE)--Anticancer Bioscience (ACB), pioneers in synthetic lethal approaches to precision oncology, announced today progress in its MYC-synthetic lethal (MYC-SL) programme.

A client of Concept Life Sciences had discovered a series of innovative peptides with strong phenotypic potency. However, progress was hindered by a lack of target engagement data, which limited the ...

Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...